[1]
S. Rüttimann, M. Danner, and M. Glaser, “Explicit versus implicit risk assessment for the indication of antithrombotic prophylaxis in acutely ill medical in-patients”, Swiss Med Wkly, vol. 135, no. 1516, pp. 228–234, Apr. 2005.